The Role of Responsibility in Gynecological Oncology

Beauchamp T.L. , Childress J.F. Principles of Biomedical Ethics, (New York, NY: Oxford University Press, 1994).

Chervenak F.A. , McCullough L.B. “What is Obstetric Ethics?”, Clin Obstet Gynecol (1992) 35: 709–719.

Tuhoey J.F. “Terminal Care and the Pregnant Woman: Ethical Reflections on In Re: A.C., Pediatrics (1991) 88: 1268–1273.

Pellegrino E. , Thomasma D.C. For the Patient's Good. The Restoration of Beneficence in Health Care, (New York, NY: Oxford University Press, 1988).

Kjaer S.K. “Risk Factor for Cervical Neoplasia in Denmark,” APMIS-Suppl. (1998) 80: 1–41.

De Sanjose S. , Bosch F.X. , Munoz N. , Shah K. Social Differences in Sexual Behavior and Cervical Cancer IARC Sci Publ. (1997) 138: 309–317.

Bosch F.X. , Manos M.M. , Munoz N. “Prevalence of Human Papillomavirus in Cervical Cancer: A Worldwide Perspective,” J. Natl Cancer Inst., (1995) 87: 796–802.

Prokopczyk B. , Cox J.E. , Hoffmann D. , Waggoner S.E. “Identification of Tobacco-Specific Carcinogen in the Cervical Mucus of Smokers and Nonsmokers,” J. Natl Cancer Inst. (1997) 89: 868–873.

Cerqueira E.M. , Santoro C.L. , Donozo N.F. “Genetic Damage in Exfoliated Cells of the Uterine Cervix. Association and Interaction Between Cigarette Smoking and Progression to Malignant Transformation?” Acta Cytol. (1998) 42: 39–649.

Szarewski A. , Jarvis M.J. , Sasieni P. “Effect of Smoking Cessation on Cervical Lesion Size,” The Lancet (1996) 347: 941–943.

Goldenberg G.L. , Runowich C.D. “Ovarian Carcinoma of Low Malignant Potential, Infertility and Induction of Ovulation - Is There a Link?” Am J Obstet Gynecol, (1992) 166: 853–854.

Whittemore A.S. “The Risk of Ovarian Cancer After Treatment for Infertility,” N Engl J Med (1994) 331: 805–806.

Nugent D. , Salha O. , Balen A.H. , Rutehford A.J. “Ovarian Neoplasia and Subfertility Treatments,” Br J Obstet Gynecol, (1998) 105: 584–591.

Harris R. , Whittemore A.S. , Intyre J. “The Collaborative Ovarian Cancer Group, Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 Case-Control Studies. III: Epithelial Tumours of Low Malignant Potential in White Women,” Am J Epidemiol (1992) 136: 1204–1211.

Brzezinski A. , Peretz T. , Mor-Yosef S. “Ovarian Stimulation and Breast Cancer: Is There a Link?” Gynecol Oncol, (1994) 52: 292–295.

Venn A. , Watson L. , Lumley J. “Breast and Ovarian Cancer Incidence After Infertility and In Vitro Fertilization,” The Lancet (1995) 346

Hempling R.E. , Wong C. , Piver M.S. “Hormone Replacement Therapy as a Risk Factor for Epithelial Ovarian Cancer: Results of a Case-Control Study,” Obstet Gynecol. (1997) 89: 1012–1016.

Persson I. “Cancer Risk in Women Receiving Estrogen-Progestin Replacement Therapy,” Maturitas (1996) 23 suppl: S37-45.

La Vecchia C. , Tavani A. , Franceschi S. , Parazzini F. “Oral Contraceptives and Cancer. A Review of the Evidence,” Drug Saf. (1996) 14: 260–272.

Tryggvadottir L. , Tulinius H. , Gudmundsdottir G.B. “Oral Contraceptive Use at a Young Age and the Risk of Breast Cancer: An Icelandic Population-Based Cohort Study of the Effect of Birth Year.” Br. J. Cancer, (1997) 75: 139–143.

Lapillonne H. , Golstein R.M. , Lapillonne A. “Duration of Pregnancy and Risk of Breast Cancer,” The Lancet (1999) 353: 2075.

Hsieh C-c , Lambe M. , Trichopoulos D. “Delivery Premature Newborns and Maternal Breast-Cancer Risk,” The Lancet (1999) 353: 12–39.

Brind J. , Chinchilli V.M. “Premature Delivery and Breast-Cancer Risk,” The Lancet (1999) 354: 424.

Dickens B.M. , Pei N. , Taylor K.M. “Legal and Ethical Issues in Genetic Testing and Counseling for Susceptibility to Breast. Ovarian and Colon Cancer,” CMAJ (1996) 154: 813–818.

Pritchard K.I. “Is Tamoxifen Effective in Prevention of Breast Cancer?” The Lancet (1998) 352: 80–81.

Bruzzi P. “Tamoxifen for the Prevention of Breast Cancer.” BMJ (1998) 316: 1181–1182.

Lancaster J.M. , Wiseman R.W. , Berchuck A. “An Inevitable Dilemma: Prenatal Testing for Mutations in the BRCA1 Breast-Ovarian Cancer Susceptibility Gene, Obstet Gynecol (1996) 87: 306–309.

Silvestri G. , Pritchard R. , Welch H.G. “Preferences for Chemiotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Descriptive Study Based on Scripted Interviews,” BMJ (1998) 317: 771–775.

Aaronson N.K. “Quality of Life Research in Oncology. Past Achievement and Future Priorities,” Cancer (1991) 67: 839–843.

Aaronson N.K. “Methodological Issues in Assessing the Quality of Life of Cancer Patients,” Cancer (1991) 67: 844–850.

Weil M. , Smith M. , Khayat D. “Truth Telling to Cancer Patients in the Western European Context,” Psycho-Oncology (1994) 3: 21–26.

Espie M. , Cuvier C. “Treatment of Breast Cancer During Pregnancy,” Contracept Fertil Steril (1996) 24: 805–810.

Di Fronzo L.A. , O'Connell T.X. “Breast Cancer During Pregnancy and Lactation.” Surg Clin North Am (1996) 76(2): 267–278.

Murray E.M. , Werner I.D. “Pregnancy and Abortion in Breast Cancer Patients. Two Case Reports and a Literature Review.” S. Afr Med J (1997) 87: 1538–9.

Hammond R. “Commentary: Pregnancy Should Not Have Affected Treatment for Melanoma,” BMJ (1998) 316: 848–851.

Sorosky J.I. , Squarito R. , Ndubisi B.U. “Stage I Squamous Cell Cervical Carcinoma in Pregnancy: Planned Delay in Therapy Awaiting Fetal Maturity,” Gynecol Oncol (1995) 59: 207–210.

Sood A.K. , Sorosky J.I. , Krogman S. “Surgical Management of Cervical Cancer Complicating Pregnancy: A Case-Control Study,” Gynecol Oncol (1996) 63: 294–298.

Petrek J.A. “Breast Cancer During Pregnancy,” Cancer (1994) 74(Isuppl): 518–527.

Aviles A. , Diaz-Maqueo J. , Talavera A. “Growth and Development of Children of Mothers Treated with Chemiotherapy During Pregnancy: Current Status of 43 Children,” Am J Hematol (1991) 36: 243–248.

Merkel D.E. “Pregnancy and Breast Cancer,” Semin Surg Oncol (1996) 12(5): 370–375.

Ebert U. , Loffler H. , Kirch W. “Cytoxic Therapy and Pregnancy,” Pharmacol Ther (1997) 74: 207–220.

Allen D.G. , Planner R.S. , Tang P.T. “Invasive Cervical Cancer in Pregnancy,” Aust NZ J Obstet Gynecol, (1995) 35(4): 408–412.

Risberg T. , Wist E. “Spiritual Healing Among Norwegian Hospitalised Cancer Patients and Patients' Religious Needs and Preferences of Pastoral Services,” Eur J Cancer (1996) 32A(2): 274–281.

Chochinov H.M. , Tatryn D. , Clinch J.J. “Will to Live in the Terminally Ill,” The Lancet (1999) 354: 816–819.